Skip to Main Content

Here you can browse the complete list of projects on CDAS whose requests for data/biospecimens were approved.

Data-Only Studies
Biospecimen Studies
Name Principal Investigator Institution Study Date Approved Project ID
Risk factors for hepatocellular carcinoma in the United States Katherine McGlynn NCI, DCEG, HREB PLCO Jul 23, 2009 2009-0154
A prospective investigation of the relationship between use of non-steroidal anti-inflammatory drugs (NSAIDs) and risk of head and neck cancers (HNC) and malignant melanomas (MM) Amanda Black NCI, DCEG, EBP PLCO Jul 23, 2009 2009-0035
Development of a Pancreatic Cancer Risk Prediction Model Martin Tammemagi Brock University / Henry Ford Health System PLCO Jul 15, 2009 2009-0095
Risk of an Abnormal Suspicious False Positive Screening Exam for Ovarian Cancer in the PLCO Cancer Screening Trial. Sarah Nyante NCI, DCEG, HREB PLCO Jul 10, 2009 2009-0059
Diet, underlying diseases, reproductive factors and CLL/SLL Huei-Ting Tsai NCI, DCEG, GEB PLCO Jun 26, 2009 2009-0106
Participant Tracking and Tracing in the PLCO and NLST/LSS Trials Pamela Marcus National Cancer Institute NLST Jun 22, 2009 200906-0040
Phase III validation using PLCO specimens of a consensus panel of ovarian cancer biomarkers developed by SPORE/EDRN investigators: Study 4: Validation using PLCO serial specimens of PLCO Ovarian Cance Nicole Urban Fred Hutchinson Cancer Research Center PLCO Jun 19, 2009 2009-0504
RISK FACTORS FOR INVASIVE BREAST CANCER BY HORMONE RECEPTOR STATUS AND FOR DUCTAL CARCINOMA IN SITU Claudine Isaacs Georgetown University PLCO Jun 18, 2009 2009-0121
Prospective evaluation of IGF and IL-6 dysregulation and multiple myeloma Mark Purdue NCI, DCEG, OEEB PLCO Jun 17, 2009 2009-0506
PLCO Participant Survey Shannon Pretzel University of Colorado Health Science Center PLCO May 28, 2009 2009-0116
Determinants of Menopausal Hormone Therapy Use in Women in the PLCO Study Bruce Kessel Pacific Health Research Institute (Hawaii) PLCO May 26, 2009 2009-0062
Cancer Recurrence after Diagnosis of Clinically Localized Prostate Cancer Sarah Daughterty NCI, DCEG, OEEB PLCO May 26, 2009 2009-0063
Nomogram predicting the risk bladder cancer and high-grade bladder cancer Andrew Stephenson Cleveland Clinic PLCO May 26, 2009 2009-0075
Factors Associated with the Timing of Follow-up After an Abnormal Cancer Screening Beth Waitzfelder Pacific Health Research Institute (Hawaii) PLCO Apr 30, 2009 2009-0023
Cohort-Based GWAS of Glioma Preetha Rajaraman NCI, DCEG, REB PLCO Apr 27, 2009 2008-0253
Detailed Analysis of Contamination and Compliance in Prostate PLCO Paul Pinsky NCI, DCP, EDRG PLCO Apr 23, 2009 2009-0076
Testing of chest x-ray computer-aided detection steve worrell Riverain Medical PLCO Apr 16, 2009 2009-0003
Body mass index and risk of thyroid cancer in a pooled analysis of cohort studies Cari Kitahara NCI, DCEG, NEB PLCO Mar 27, 2009 2009-0048
Vitamin D and Risks of Prostate and Colorectal Cancers: Study Update and Expansion Regina Ziegler - PLCO Feb 13, 2009 2008-0224
Examining Questionnaire-Based Risk Factors for Colorectal Cancer in the PLCO Cancer Screening Trial: Smoking behavior Linda Laio NCI, DCEG, OEEB PLCO Feb 13, 2009 2009-0040